More recently, a study found that PLN R14del mutation carriers are at high risk for malignant ventricular arrhythmias and end-stage heart failure, with left ventricular ejection fraction <45% and sustained or nonsustained ventricular tachycardia as independent risk factors12. This evidence concerns the gene PLN and Ventricular arrhythmia.